Hee Chul Nam

526 total citations
22 papers, 327 citations indexed

About

Hee Chul Nam is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Hee Chul Nam has authored 22 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 11 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Hee Chul Nam's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (7 papers). Hee Chul Nam is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (7 papers). Hee Chul Nam collaborates with scholars based in South Korea, United States and Philippines. Hee Chul Nam's co-authors include Seung Kew Yoon, Jong Young Choi, Jeong Won Jang, Pil Soo Sung, Si Hyun Bae, Hae Lim Lee, Sung Won Lee, Jung Hyun Kwon, Nam Ik Han and Sun Hong Yoo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Gut.

In The Last Decade

Hee Chul Nam

22 papers receiving 326 citations

Peers

Hee Chul Nam
Virginia Knight Australia
Morven Cunningham United Kingdom
Hyun Yang South Korea
Evangelia Fatourou United Kingdom
Yuki Kugiyama Japan
Yuki Tahata Japan
Noritaka Wakui Japan
Valentina Monti Italy
Masakuni Tateyama Japan
Víctor Sapena Spain
Virginia Knight Australia
Hee Chul Nam
Citations per year, relative to Hee Chul Nam Hee Chul Nam (= 1×) peers Virginia Knight

Countries citing papers authored by Hee Chul Nam

Since Specialization
Citations

This map shows the geographic impact of Hee Chul Nam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hee Chul Nam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hee Chul Nam more than expected).

Fields of papers citing papers by Hee Chul Nam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hee Chul Nam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hee Chul Nam. The network helps show where Hee Chul Nam may publish in the future.

Co-authorship network of co-authors of Hee Chul Nam

This figure shows the co-authorship network connecting the top 25 collaborators of Hee Chul Nam. A scholar is included among the top collaborators of Hee Chul Nam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hee Chul Nam. Hee Chul Nam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sung, Pil Soo, Ji Won Han, Joseph Ahn, et al.. (2021). Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant. Frontiers in Pharmacology. 12. 685176–685176. 6 indexed citations
2.
Han, Ji Won, et al.. (2021). Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis. Clinical and Molecular Hepatology. 28(2). 219–231. 22 indexed citations
3.
Lee, Soon Kyu, Hee Chul Nam, Pil Soo Sung, et al.. (2021). Use of M2BPGi in HCC patients with TACE. Journal of Gastroenterology and Hepatology. 36(10). 2917–2924. 7 indexed citations
4.
Sung, Pil Soo, Jeong Won Jang, Jaejun Lee, et al.. (2020). Real-World Outcomes of Nivolumab in Patients With Unresectable Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus Infection. Frontiers in Oncology. 10. 1043–1043. 27 indexed citations
5.
Nam, Hee Chul, Jong Young Choi, Seung Kew Yoon, et al.. (2020). Effectiveness of sorafenib dose modifications on treatment outcome of hepatocellular carcinoma: Analysis in real‐life settings. International Journal of Cancer. 147(7). 1970–1978. 16 indexed citations
6.
Lee, Jaejun, Pil Soo Sung, Hyun Yang, et al.. (2020). A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC. Journal of Clinical Medicine. 9(12). 4121–4121. 27 indexed citations
7.
8.
9.
Nam, Hee Chul, Pil Soo Sung, Eun Sun Jung, & Seung Kew Yoon. (2019). Solitary fibrous tumor of the liver mimicking malignancy. The Korean Journal of Internal Medicine. 35(3). 734–735. 4 indexed citations
10.
Nam, Hee Chul, Pil Soo Sung, Do Seon Song, et al.. (2019). Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma. International Journal of Clinical Oncology. 24(6). 666–676. 7 indexed citations
11.
Sung, Pil Soo, Keungmo Yang, Si Hyun Bae, et al.. (2019). Reduction of Intrahepatic Tumour by Hepatic Arterial Infusion Chemotherapy Prolongs Survival in Hepatocellular Carcinoma. Anticancer Research. 39(7). 3909–3916. 23 indexed citations
12.
Sung, Pil Soo, Dong Jun Park, Jung‐Hee Kim, et al.. (2019). Ex vivo Detection and Characterization of Hepatitis B Virus-Specific CD8+ T Cells in Patients Considered Immune Tolerant. Frontiers in Immunology. 10. 1319–1319. 15 indexed citations
13.
Jang, Jeong Won, Sun Hong Yoo, Hee Chul Nam, et al.. (2019). Association of Prophylactic Anti–Hepatitis B Virus Therapy With Improved Long-term Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Therapy. Clinical Infectious Diseases. 71(3). 546–555. 9 indexed citations
14.
Yang, Hyun, Hyun Young Woo, Soon Kyu Lee, et al.. (2017). A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function. Clinical and Molecular Hepatology. 23(2). 128–137. 28 indexed citations
15.
Lee, Hae Lim, Si Hyun Bae, Hyun Yang, et al.. (2017). Reactivation of Hepatitis C Virus and Its Clinical Outcomes in Patients Treated with Systemic Chemotherapy or Immunosuppressive Therapy. Gut and Liver. 11(6). 870–877. 24 indexed citations
16.
Nam, Hee Chul, Hae Lim Lee, Hyun Yang, & Myeong Jun Song. (2016). Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection. Clinical and Molecular Hepatology. 22(2). 259–266. 5 indexed citations
17.
18.
Lee, Jayoung, et al.. (2012). Renal artery thrombosis secondary to sepsis-induced disseminated intravascular coagulation in acute pyelonephritis. SHILAP Revista de lepidopterología. 31(4). 242–245. 5 indexed citations
19.
Park, Youn Jung, et al.. (2012). A Case of Hemolytic Uremic Syndrome in a Lung Cancer Patient Treated with Gemcitabine. Tuberculosis & respiratory diseases. 72(2). 207–207. 1 indexed citations
20.
Kim, Ka Young, et al.. (2012). A Case of Adipsic Hypernatremia Associated with Anomalous Corpus Callosum in Adult with Mental Retardation. Endocrinology and Metabolism. 27(3). 232–232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia Knight Breakdown of academic impact, for papers by Morven Cunningham Breakdown of academic impact, for papers by Hyun Yang Breakdown of academic impact, for papers by Evangelia Fatourou Breakdown of academic impact, for papers by Yuki Kugiyama Breakdown of academic impact, for papers by Yuki Tahata Breakdown of academic impact, for papers by Noritaka Wakui Breakdown of academic impact, for papers by Valentina Monti Breakdown of academic impact, for papers by Masakuni Tateyama Breakdown of academic impact, for papers by Víctor Sapena
Rankless by CCL
2026